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Background: Primary evaluation of patients with pulmonary atresia with ventri-
cular septal defect (PA-VSD) traditionally relies upon echocardiography and con-
ventional cardiac angiography (CCA). Cardiac angiography is considered the gold 
standard for delineation of anatomy in children with PA-VSD. Data comparing CCA 
and dual-source multidetector-row computed tomography angiography (MDCT) in 
PA-VSD patients is limited. The objective of this study was to test the hypothesis 
that MDCT is equivalent to CCA for anatomic delineation in these patients. 
Materials and methods: Twenty-eight patients with PA-VSD underwent CCA and 
MDCT in close proximity to each other without interval therapy. A retrospective 
review of these 28 patients was performed. All MDCT data of pulmonary artery 
morphology, major aortopulmonary collateral arteries (MAPCAs) and type of blood 
supply (dual vs. single supply) were evaluated by blinded experts and results were 
compared with CCA. 
Results: Twenty-eight patients had adequate size right and left pulmonary arteries 
(21 confluent and 7 non-confluent). Seven patients had complete absence of 
native pulmonary artery and 3 patients had stenosis of distal branches of pulmo-
nary arteries; all had MAPCAs from descending thoracic aorta and/or subclavian 
arteries. Sensitivity, specificity, positive and negative predictive value of MDCT for 
detecting confluent of pulmonary arteries, absence of native pulmonary artery and 
stenosis of pulmonary arteries were all 100%. Moreover, accuracy of detecting 
MAPCAs was excellent.
Conclusions: These results suggest that MDCT and CCA are equivalent in their 
ability to delineate pulmonary artery anatomy and MAPCAs. Dual source MDCT 
provides high diagnostic accuracy in evaluation of pulmonary blood supply in 
patients with PA-VSD and allows precise characterisation of the condition of 
pulmonary arteries and MAPCAs which is of paramount importance in managing 
patients with PA-VSD. (Folia Morphol 2018; 77, 1: 116–122)
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INTRODUCTION
Pulmonary atresia with ventricular septal defect (PA-
VSD) belong to a group of congenital cardiac malforma-
tions characterised by the lack of luminal continuity and 
blood flow from either the ventricle and the pulmonary 
artery, together with ventricular septal defect [5, 6, 10, 
17, 22]. The pulmonary circulation in PA-VSD can be 
supplied with native pulmonary arteries, systemic cir-
culation from patent ductus arteriosus (PDA) or major 
aortopulmonary collateral arteries (MAPCAs), or a com-
bination of the two [6, 15, 22]. Major aortopulmonary 
arteries are large systemic collateral arteries, typically 
one to six in number but sometimes more, usually 
originating from the descending thoracic aorta [11]. 
Occasionally they arise from subclavian artery, aortic 
arch or abdominal aorta or uncommonly from other 
systemic arteries such as carotid, or coronary arteries 
[11, 22]. They most commonly terminate by joining 
an interlobar or intralobar pulmonary artery that ar-
borizes normally within a pulmonary lobe or segment, 
but they distribute distally into the lungs and do not 
communicate with the central pulmonary artery system 
in some cases [11]. Most patients with PA-VSD have 
a diffusely enlarged network of bronchial arteries pro-
viding a nondiscrete source of the pulmonary circula-
tion [11]. They are usually smaller and more numerous 
than MAPCAs [11, 22]. Nonbronchial systemic arteries, 
such as the paramediastinal collateral arteries and the 
intercostals collateral arteries, also supply the lungs 
[11]. The morphology of these vessels can be highly 
complex by nature, and they can undergo changes 
during the course of disease.
Some progress to stenosis and complete occlu-
sion, and others without stenoses usually become 
hypertensive [3]. On the basis of the characterisation 
of the pulmonary circulation, PA-VSD is classified into 
three types [22]. In type A, the native pulmonary arter-
ies are present and are supplied by the PDA. In type 
B, pulmonary blood flow is provided by both native 
pulmonary arteries and by MAPCAs. In type C, native 
pulmonary arteries are absent and the blood supply 
is only through MAPCAs. When surgical management 
of PA-VSD is possible, MAPCAs are unified at the hi-
lum, right ventricular pulmonary arterial continuity is 
established, and the VSD is closed [11, 19]. 
Primary evaluation of patients with PA-VSD tra-
ditionally relies upon echocardiography and con-
ventional cardiac angiography, both of which have 
potential limitations [1, 14]. Echocardiography is an 
operator dependent and limited by small window. 
Furthermore, echocardiography does not provide 
the surgeon with a precise anatomical roadmap. 
Although conventional cardiac angiography (CCA) 
has long been accepted for preoperative evaluation 
to obtain an accurate map of pulmonary circulation, 
it is an invasive procedure with a risk of catheter 
complications. Both surgery and endovascular inter-
ventions are not always feasible and are associated 
with complications [3, 11, 19].  
The use of multidetector-row computed tomogra-
phy angiography (MDCT) for evaluation of MAPCAs 
has been reported with older-generation scanners  
using three-dimensional (3D) imaging software, 
a complex pulmonary blood supply can noninvasively 
and accurately imaged with high-resolution MDCT 
[2, 12, 13, 16]. Precise characterisation of the condi-
tion of pulmonary arteries and MAPCAs is of para-
mount importance in managing patients with PA-VSD. 
Development of newer scanner such as dual-source 
MDCT uses two X-ray tubes and detectors to achieve 
an improved temporal resolution of 83 ms. with 
a gantry rotation time of 330 ms with use of a sin-
gle-segment reconstruction mode [20]. This newer 
scanner MDCT provides an alternative to alleviate 
these pitfalls of traditional cardiac diagnostic stud-
ies. Therefore, the purpose of the current study was 
to evaluate the diagnostic accuracy of dual source 
MDCT in the identification and the comprehensive 
evaluation of patients with PA-VSD compared with 
CCA as the standard of reference.
MATERIALS AND METHODS
Patient population
This retrospective study included 28 patients with 
diagnosis of PA-VSD who underwent both MDCT 
and CCA, between February 2013 and December 
2014. The indications for MDCT were preoperative 
evaluation of PA-VSD patients which is considered ap-
propriate indications for MDCT, based on the criteria 
of the American College of Cardiology (ACC) [21]. 
Exclusion criteria for MDCT included the presence 
of renal failure, and a history of allergic reaction to 
iodine-containing contrast agents. 
Dual-source MDCT scanning protocol
Short-term IV sedation is often required, particu-
larly in children under 5 years of age, and the imaging 
can be performed during quiet breathing. Imaging 
was performed by using a dual-source MDCT scanner 
(Somatom Definition; Siemens Healthcare, Forchheim, 
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Germany). The radiation dose is kept to minimum by 
reducing the kilovoltage and tube current appropri-
ately. For children weighing less than 10 kg, 10–19 kg 
and 20–30 kg, we use 80 kV and 80 mAs, 80 kV 
and 100 mAs, and 100 kV and 120 mAs, respectively. 
Other cardiac computed tomography angiographic 
parameters were as follows: number of X-ray tubes, 
two; collimation, 128 detector rows of 0.5 mm each, 
with double sampling by using rapid alteration of the 
focal spot in the longitudinal direction (z flying focal 
spot) [7]. Prior to scanning, the pitch was set automati-
cally by the scanner software. Depending on heart rate, 
pitch was set between 0.2 and 0.43. Automated dose 
regulation methods such as CARE dose 4D (Siemens 
Healthcare) may be used to reduce the radiation.
Image acquisition was performed during inspira-
tory breath-hold for older children or adult. To famil-
iarise the patient with the protocol, breath-holding 
was practiced before the examination. A bolus of 
iodinated contrast material (350 mg/mL, Omnipaque; 
GE Healthcare) at a dose of 1.5 mL/kg with dual-
head power injector at a rate of 1.5–2.0 mL/s for 
a 22-gauge cannula, 3.0 mL/s for a 20-gauge cannula 
and 4.0–5.0 mL/s for a 18-gauge cannula followed by 
a 10–20 mL of saline flush at a same rate to that of the 
contrast injection. For timing purposes, an automated 
bolus-tracking software was used, starting the scan 
automatically 6 s after contrast agent density in the 
descending aorta reached a predefined threshold of 
130 HU [4]. The entire volume of the heart and pul-
monary arteries was covered during one breath-hold 
in approximately 5 s with simultaneous recording of 
the electrocardiography trace. Patients were scanned 
in the supine position. MDCT is performed from the 
thoracic inlet level to L1–L2. When there is suspicion 
of anomalous pulmonary venous drainage, the scan 
can be extended down to the lower border of the liver.
MDCT image analysis
MDCT image analysis was performed by two car-
diovascular and thoracic radiologists in consensus 
(with a respective 11 and 10 years of experience in 
examining cardiovascular and thoracic computed 
tomography scans) and blinded to the clinical data 
and the results of CCA data. First, axial all image 
data are evaluated using a 3D post processing work-
station with Syngo software (Siemens Healthcare). 
Various image reformatting techniques including 
curved planar reconstruction, maximum intensity 
projection (MIP), minimum intensity projection, and 
volume-rendering technique (VRT) are used to get 
all the clinically relevant information. Curved planar 
reformatting and MIP are primarily used to evaluate 
curved structures such as the pulmonary arteries and 
MAPCAs. Minimum intensity projection is used to 
evaluate the airway and lung parenchyma. For 3D 
reformatting of the complex anatomy, the VRT is 
used. Thin-section multiplanar reformatting is used 
for quantitative analysis of the structure in question.
On the basis of the characterisation of the pulmo-
nary circulation, PA-VSD is classified into three types. 
In type A, the native pulmonary arteries are present 
and are supplied by the PDA. In type B, pulmonary 
blood flow is provided by both native pulmonary 
arteries and by MAPCAs. In type C, native pulmo-
nary arteries are absent and the blood supply is only 
through MAPCAs [11, 17, 22] as illustration shown 
on Figure 1.
Figure 1. Illustration demonstrates classification of pulmonary atresia (PA) with ventricular septal defect according to the native PA, patent 
ductus arteriosus (PDA), and major aortopulmonary collateral artery (MAPCA); Ao — aorta; Type A — Native pulmonary artery present  
feeding by PDA; Type B — Native pulmonary artery and MAPCA present; Type C — Absence of native pulmonary artery, only MAPCA  
maintains pulmonary blood flow.
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Conventional coronary angiography
Conventional coronary angiography was per-
formed according to standard techniques. Images 
were evaluated by an experienced cardiologist blind-
ed to MDCT results using a validated and dedicated 
quantitative coronary angiography (QCA) software 
package (CA-CMS, QAngioXA 6.0, Medis Medical 
Imaging Systems, Leiden, The Netherland). 
Statistical analysis
Sensitivity, specificity, and positive predictive value 
(PPV) and negative predictive value (NPV), including 
95% confidence intervals (CI), for the detection of > 
50% luminal narrowing of pulmonary artery were con-
sidered positive (> 50% luminal narrowing) on CCA. 
Continuous data were expressed as mean ± standard 
deviation (SD). Statistical analyses were performed us-
ing SPSS software version 16 (SPSS, Inc., Chicago, IL, 
USA). A significance level of p < 0.05 was considered 
a statistically significant result and all reported p-values 
were two-sided. Means were compared using unpaired 
t-test, and Mann-Whitney rank sum was used when 
data was not normally distributed.
RESULTS
Patient clinical characteristics are presented in 
Table 1. Twenty-eight patients (10 boys, 18 girls; mean 
age, 9 ± 8 years; range, 3–14 years) were included 
in this study over a period of 22 months. The mean 
time interval between MDCT and CCA was 3 ± 10 
days (range, 2–21 days) and there were no clinical 
events between the two studies in any patient. In 
most patients (25/28), MDCT was performed before 
CCA, and in 3 patients, CCA was performed first. 
In patient analysis, out of 28 MDCT examinations, 
none of them was of non-diagnostic image quality. 
CCA identified 20 patients with confluent pulmonary 
arteries. All patients (100%) were correctly identified 
by MDCT. In addition, in a total of 28 patients, MDCT 
correctly identified the presence of non-confluent 
pulmonary arteries in 8 patients. Importantly, no 
patients with non-confluent pulmonary arteries were 
missed by MDCT. Therefore, the sensitivity and speci-
ficity for the detection of confluent or non-confluent 
pulmonary arteries were all 100%. In addition, PPV 
and NPV were all 100%. 
Five patients had complete absence of native pul-
monary artery and 3 patients had stenosis of proximal 
branches of pulmonary arteries; all had MAPCAs from 
descending thoracic aorta and/or subclavian arteries. 
In a total of 28 patients, 3 patients were correctly 
classified as PA-VSD type A on MDCT (Fig. 2, true posi-
tive), whereas 20 patients were correctly classified as 
PA-VSD type B on MDCT and 5 patients were correctly 
classified as PA-VSD type C on MDCT. Consequently, 
the sensitivity, specificity, PPV and NPV for the clas-
sification of PA-VSD were all 100%. 
For pulmonary collateral vessels evaluated, no 
statistical significant of a total of 84 collateral vessels 
were identified on MDCT and 85 collateral vessels 
were identified on CCA (p = 0.78). 
MDCT was equivalent to CCA to identification of 
PDA, 3 PDA were identified on both MDCT and CCA 
(p = 1). No statistical significant of MDCT and CCA 
to identified MAPCAs (MDCT = 81 vessels, CCT = 82 
vessels, p = 0.86). The MAPCA was incorrectly identi-
fied by MDCT in only 1 vessel resulting in a sensitivity 
and specificity of 98.7% and 100%, respectively, and 
PPV and NPV were 100% and 98.7%, respectively. 
The diagnostic accuracy for the detection of conflu-
ent pulmonary arteries, PDA and MAPCAs as Table 2.
DISCUSSION
The present study demonstrated excellent diag-
nostic accuracy for the comprehensive assessment of 
patient with PA-VSD using dual-source MDCT. Impor-
tantly, no patients with absence of native pulmonary 
artery or non-confluent pulmonary artery were missed 
using dual-source MDCT. 
Furthermore, the excellent sensitivity, specificity, 
PPV and NPV suggests that MDCT might be particu-
larly valuable in the evaluation of pulmonary collat-
eral vessels such as PDA or MAPCAs compared with 
conventional cardiac angiography. These results are in 
line with previous published data on the performance 
of the older generation computed tomography scan-
ner [2, 12, 13, 16].
Analysis of the pulmonary artery anatomy is the 
most important aspect of diagnostic imaging of patients 
Table 1. Patient characteristics (n = 28)
Characteristic Value; mean ± SD (range)
Age [years] 7 ± 8 (2–14)
Men 10 (35.7%)
Height [cm] 110.8 ± 13
Weight [kg] 19 ± 5
Body mass index [kg/m2] 15.7 ± 5 (14–24)
SD — standard deviation
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with PA-VSD. Various studies have shown that MDCT 
is an accurate tool for evaluating pulmonary arteries 
[4, 12, 13]. The presence or absence of native pulmonary 
artery, length of the pulmonary atresia, confluence of 
native main pulmonary arteries, size of main, right, 
and left pulmonary arteries at the origin and at pre-
branching site were recorded. Images were carefully 
analysed for branch pulmonary artery stenosis [18].
In patients with PA-VSD, the lungs can derive their 
blood supply from various sources [11, 17, 22]. MAP-
CAs represent fetal primitive intersegmental arteries 
that originate from the descending aorta and have 
Table 2. Diagnostic accuracy of dual-source multidetector computed tomography for pulmonary atresia with ventricular septal defect 
patients compared with conventional cardiac angiography
Confluent PA PDA MAPCAs
Sensitivity 20/20 (100%) 3/3 (100%) 81/82 (98.7%, 95–99)
Specificity 8/8 (100%) 25/25 (100%) 81/81 (100%)
Positive predictive value 20/20 (100%) 3/3 (100%) 81/81 (100%)
Negative predictive value 8/8 (100%) 25/25 (100%) 81/82 (98.7%, 95–99%)
Data are absolute values used to calculate percentages. Data in parentheses are percentages with 95% confidence intervals; MAPCA — major aortopulmonary collateral artery;  
PA — pulmonary artery; PDA — patent ductus arteriosus
Figure 2. A 10-year-old boy with pulmonary atresia with ventricular septal defect (VSD). Dual-source multidetector computed tomography 
(A, B) image shows the major aortopulmonary collateral artery (MAPCA) supplying the left lung. Conventional cardiac angiography (CCA) (C) 
confirms the large MAPCA from descending thoracic aorta (Ao) feeding left pulmonary artery (PA).
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not involuted. They gain access to the lung through 
the hilum and connect with native pulmonary arteries 
in the mediastinum or at the lobar or subsegmental 
level. MAPCAs are different from bronchial arteries 
in a number of ways [8]. Usually, MAPCAs do not 
branch in their mediastinal course, whereas bronchial 
arteries provide mediastinal branches and, in some 
cases, branches to the spinal cord. MAPCAs anasto-
mose with the intrapulmonary arteries typically at or 
near the pulmonary hilum instead of in the periphery. 
MAPCAs may accompany bronchi but do not form 
a nutritive plexus around bronchi. Unlike bronchial 
arteries, MAPCAs are virtually never connected to in-
tercostals arteries. Most MAPCAs have an elastic wall 
structure resembling the pulmonary artery or aorta 
rather than bronchial arteries. MDCT with 3D VRT has 
the potential to elucidate all the MAPCAs shown by 
invasive catheter angiography [8, 9, 16]. Using various 
MDCT post processing techniques, the total number 
of MAPCAs and their origin, course, and intrapul-
monary connections can be easily assessed. PDA, if 
present, is an important source of pulmonary blood 
supply. When ductus arteriosus is patent, generally 
the native pulmonary arteries will be of adequate size. 
When a PDA connects with a central pulmonary artery, 
the peripheral distribution is normal, and there are 
no MAPCAs in that hemithorax. Thus, a PDA does not 
coexist with MAPCAs in the same lung [22]. Unlike 
MAPCAs, the ductus does not branch before joining 
the central pulmonary arteries, and it tends to be 
less tortuous. There is a high risk of stenosis of the 
pulmonary arteries at the PDA insertion site.
Clinical progress by the development of MDCT 
technology beyond 4 slices can more likely be ex-
pected from increased temporal resolution which 
reduces cardiac motion artifacts and increased spatial 
resolution rather than from only increase in the vol-
ume coverage speed. The limitations of earlier MDCT 
systems in the assessment of cardiac and pulmonary 
arteries are the consequence of partial volume ef-
fects and beam-hardening artifacts which could be 
overcome by a higher isotropic spatial resolution. 
The total scanning time for a dual-source MDCT is 
shortened to approximately 5 s. Accordingly, faster 
image acquisition allows for a reducing the volume 
of contrast media and breath-hold time causing re-
ducing respiratory motion artifacts, and making the 
technique more robust [4, 7, 8, 9, 18].
Despite promising initial results, our study has 
potential limitations. First, since our method of en-
rollment included some patients who underwent 
CCA because of MDCT results, selection bias in 
a proportion of patients may have overestimated the 
calculated sensitivity of MDCT. However, selection 
bias tends to underestimate specificity, which was 
still high in our study, and may have had minimal 
effect on PPV and NPV because patient enrollment 
after initial MDCT was independent of the actual true 
disease status on CCA. Secondly, the present result 
is limited by the number of patients, therefore, the 
interpretation of sensitivity may be limited. Thirdly, 
our results represent a single-center experience, the 
generalisability of the present results is limited. 
CONCLUSIONS
Dual-source MDCT provides a comprehensive eval-
uation of different anatomic structures, including the 
heart, pulmonary and systemic thoracic vasculature 
when evaluating patients with PA-VSD. In a clinical 
setting, MDCT has proved to be an invaluable diag-
nostic and decision-making tool as a compliment to 
echocardiography and increasingly as a substitute 
for invasive angiography. The advantage of MDCT 
compared with CCA is that it is noninvasive, allows 
avoiding most catheter-associated risks and discom-
forts with the exception of exposure to iodinated 
contrast agents and radiation. With rapidly improv-
ing technology, MDCT may well evolve from a useful 
complement to CCA to a clinically viable alternative. 
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